BioSpace News Archive

Lifestyle Delivery Systems Inc. (CSE: LDS), (OTCQX: LDSYF), (Frankfurt: LD6, WKN: A14XHT) (“LDS” or the “Company”) announces that Highway 395 Dispensary has received approvals for environmental impact and yucca tree preservation requirements.

The global non-small cell lung cancer drugs market is expected to post a CAGR of more than 13% during the period 2019-2023, according to the latest market research report by Technavio.

A new study by the University of Cincinnati Economics Center finds that the Ohio operations of biopharmaceutical company Allergan have a significant impact on the state’s economy and communities.

The Association of Clinical Research Organizations (ACRO) is pleased to announce the expansion of its membership to include ERT, Oracle and Veeva.

The global automated breast ultrasound systems (ABUS) market 2019-2023 is expected to post a CAGR of more than 14% during the forecast period, according to the latest market research report by Technavio.

For decades, independently owned pharmacies have maintained a reputation for locally rooted, personalized service.

International law firm McDermott Will & Emery has launched its new Compliance Toolkit and Checkup program for Physician Practice Management (PPM) organizations.

Ian Jenkins, CEO of Frelii Inc. (OTCQB: FRLI) (“Frelii” or “The Company”) met in an informal meeting with Canadian Prime Minister, Justin Trudeau to discuss how Frelii’s artificial intelligence (AI) technology could be beneficial in advancing the safe and more effective use of medical cannabis products in Canada.

AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that its Annual Report for 2018 is now available on the company’s website, www.alzecurepharma.se.

Alchem International Private Limited (“Alchem”), a privately held pharmaceutical company focusing on the production of plant-derived active pharmaceutical ingredients (API); today announced the launch of its proprietary micronized digoxin platform.